WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (“Eagle” or “the Company”) (NASDAQ:EGRX) today announced that it has appointed Michael Moran, a seasoned sales executive in the pharmaceuticals industry, to the role of U.S. Head of Sales, effective immediately.
“Mike is an exceptional sales leader with a lengthy record of success in this industry, and we are very pleased to have him aboard,” said Scott Tarriff, President and Chief Executive Officer. “His extensive experience and innovative selling strategies will make him a valuable asset to Eagle as we continue to develop our sales capabilities, strengthening our market position as a fully commercial specialty company with a broad and growing portfolio. In particular, we expect to leverage his expertise to coordinate our co-promotional activities with Spectrum Pharmaceuticals, as we finalize building our 20 person internal sales force.
